Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16623848 | 0.84 | PTPN1 (0.39) | PTPN1PTPN2L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL16623840 | 0.81 | PTPN1 (0.44) | PTPN1PTPN2MEN1KMT2AATM | |
| SCHEMBL16623699 | 0.81 | PTPN1 (0.44) | PTPN1PTPN2MEN1KMT2AATM | |
| SCHEMBL16623845 | 0.80 | PTPN1 (0.42) | PTPN1PTPN2MEN1KMT2AATM | |
| SCHEMBL16623782 | 0.76 | GPR3 (0.43) | MEN1KMT2AATMKDM4EALDH1A1 | |
| SCHEMBL16623844 | 0.76 | PTPN1 (0.41) | PTPN1PTPN2MEN1KMT2AATM | |
| SCHEMBL16623708 | 0.75 | PTPN1 (0.42) | PTPN1PTPN2MEN1KMT2AATM | |
| SCHEMBL16623706 | 0.75 | PTPN1 (0.39) | PTPN1PTPN2MEN1KMT2AATM | |
| SCHEMBL16623709 | 0.71 | PTPN1 (0.38) | PTPN1PTPN2MEN1KMT2AATM | |
| SCHEMBL16623849 | 0.71 | PTPN1 (0.42) | PTPN1PTPN2MEN1KMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180047913-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | JNC CORPORATION (JP) | 2018-02-15 | — | — | US | disclosed |
| US-9741950-B2 | Polycyclic aromatic compound | KYOTO UNIVERSITY (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20160049600-A1 | POLYCYCLIC AROMATIC COMPOUND | SK MATERIALS JNC CO., LTD. (KR) | 2016-02-18 | — | — | US | disclosed |
| US-9166176-B2 | Polycyclic aromatic compound | KYOTO UNIVERSITY (JP) | 2015-10-20 | — | — | US | disclosed |
| US-20150097162-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | JNC CORPORATION (JP) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180047913-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | L1CAM, VDAC1, VDAC2 | PTPN1 601/4885PTPN2 514/4885MEN1 3704/4885 |
| US-20160049600-A1 | POLYCYCLIC AROMATIC COMPOUND | BICRA, PAH, SMARCC2 | PTPN1 1388/4885PTPN2 1697/4885MEN1 875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.